Pregnancy outcomes in interferon-beta-exposed patients with multiple sclerosis: results from the European Interferon-beta Pregnancy Registry

An Update on the Use of Disease-Modifying Therapy in Pregnant Patients with Multiple Sclerosis

(2018) Caila Vaughn et al.   CNS DRUGS

ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis

(2018) X. Montalban et al.   EUROPEAN JOURNAL OF NEUROLOGY

ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis

(2018) Xavier Montalban et al.   Multiple Sclerosis Journal

ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis

(2018) Xavier Montalban et al.   Multiple Sclerosis Journal

Treatment of multiple sclerosis during pregnancy – safety considerations

(2017) Jan Thöne et al.   Expert Opinion On Drug Safety

Interferon-beta exposure during first trimester is safe in women with multiple sclerosis—A prospective cohort study from the German Multiple Sclerosis and Pregnancy Registry

(2016) Sandra Thiel et al.   Multiple Sclerosis Journal

Interferon-beta exposure during first trimester is safe in women with multiple sclerosis—A prospective cohort study from the German Multiple Sclerosis and Pregnancy Registry

(2016) Sandra Thiel et al.   Multiple Sclerosis Journal

Monitoring of Congenital Anomalies in Latvia

(2016) Irisa Zīle et al.   Central European Journal of Public Health

Pregnancy outcomes in patients exposed to interferon beta-1b: Table 1

(2014) Rebecca S Romero et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Final results from the Betaseron (interferon β-1b) Pregnancy Registry: a prospective observational study of birth defects and pregnancy-related adverse events

(2014) P K Coyle et al.   BMJ Open

Trends of reporting of ‘serious’vs. ‘non-serious’ adverse drug reactions over time: a study in the French PharmacoVigilance Database

(2012) Guillaume Moulis et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Disease-modifying drugs for multiple sclerosis in pregnancy: A systematic review

(2012) E. Lu et al.   NEUROLOGY

Multiple sclerosis and pregnancy: experience from a nationwide database in Germany

(2012) Kerstin Hellwig et al.   Therapeutic Advances in Neurological Disorders

Pregnancy outcomes in multiple sclerosis following subcutaneous interferon beta-1a therapy

(2011) Magnhild Sandberg-Wollheim et al.   Multiple Sclerosis Journal

Pregnancy and fetal outcomes after interferon-  exposure in multiple sclerosis

(2010) M. P. Amato et al.   NEUROLOGY

Multiple sclerosis, immunomodulators, and pregnancy outcome: a prospective observational study

(2009) C Weber-Schoendorfer et al.   Multiple Sclerosis Journal

Is in utero early-exposure to interferon beta a risk factor for pregnancy outcomes in multiple sclerosis?

(2008) F. Patti et al.   JOURNAL OF NEUROLOGY